January, 2024

article thumbnail

Advise Patients On Five Tips When Consuming Vitamins, Supplements, Energy Drinks

Pharmacy Times

By offering personalized guidance, promoting awareness, and fostering open communication, pharmacists can empower their patients to navigate the new year with a focus on both wellness and safety.

article thumbnail

Opinion: Defunding liberal arts is dangerous for health care

STAT

If you want an argument in favor of teaching the humanities, I suggest you ask a medical educator. Across the U.S., the age-old debate about the value of a liberal arts education has seemingly devolved into mortal combat, leaving the humanities in dire straits on college campuses. For example, the Atlantic recently reported on West Virginia University’s decision to gut its humanities programming, and the New York Times wondered whether the liberal arts will exist after the budget cuts hap

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A category in chaos

Drug Store News

The future of phenylephrine, a widely used OTC decongestant, is up in the air.

116
116
article thumbnail

To Crush or Not to Crush: That is the Medication Administration Question

Pharmacy Times

Pharmacists are well suited to identify patients with dysphagia and educate patients and caregivers on when and how to safely crush and administer medication.

158
158
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Prescribing Success: Dr. Linda Gutierrez-Miller’s Journey to Impactful Clinical Pharmacy and Inspiring Resilience!

Pharmacy Is Right For Me

“How can I make the biggest difference in the lives of others? How can I help the most people?” These questions often cross the minds of students as they navigate the labyrinth of career choices. Dr. Linda Gutierrez-Miller, one such student, embarked on a journey to answer these questions, ultimately choosing a career path that aligns with her goals of making a substantial impact and aiding a diverse range of individuals—clinical pharmacy.

article thumbnail

Paxlovid Found Not to Reduce Long COVID Risk

Drug Topics

A new study found that 16.1% of patients treated with nirmatrelvir-ritonavir (Paxlovid) reported long COVID symptoms, compared to 14% of untreated patients.

241
241

More Trending

article thumbnail

Some dementia patients might have reversible symptoms caused by cirrhosis, study says

STAT

The descent into dementia can feel like traversing a minefield, coming across new symptoms without the hope of a cure. But some dementia patients, even up to 10% of people diagnosed with the condition, might actually have undiagnosed liver disease and accompanying neurological problems, a new study in JAMA Open Network suggests. Most importantly, it’s possible their liver-related brain symptoms could be resolved with treatment.

145
145
article thumbnail

‘Medicine is going personalised’: Moderna’s UK boss on the coming vaccine revolution

The Guardian - Pharmaceutical Industry

Darius Hughes was a key figure in Pfizer’s pioneering Covid vaccine drive. Now he has changed companies – and sees a big future for mRNA technology The man who launched Pfizer’s Covid-19 vaccine in the UK three years ago – when 90-year-old Margaret Keenan in Coventry became the first person in the world to receive one – is now overseeing the construction of a manufacturing and research centre in Oxfordshire for rival US jab maker Moderna.

Vaccines 144
article thumbnail

Obstetrical Patient Dies After Inadvertent Administration of Digoxin for Spinal Anesthesia

Pharmacy Times

The ampule of digoxin was accidentally taken from automated dispensing cabinet instead of bupivacaine

181
181
article thumbnail

Navigating A Unique Journey: Dr. Lindsey Moseley’s Inspiring Path in Pharmacy Education

Pharmacy Is Right For Me

A pharmacy education provides diverse opportunities, ranging from patient care and research to education. Truly, no one path looks the same and there is no better example than Dr. Lindsey Moseley who found her passion for teaching and education whilst pursuing her Pharm.D. degree. Facing An Identity Crisis Dr. Lindsey Moseley is the Curricular Coordinator and a faculty member at Auburn University Harrison College of Pharmacy.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Florida Drug Importation Program Faces Nationwide Opposition From Pharmacy Organizations

Drug Topics

Just weeks after it gained FDA approval, pharmacy organizations have come forward to voice concerns about the safety and security of Florida’s drug importation program.

FDA 227
article thumbnail

UnitedHealth Group kicks off payer earnings, reports $5.5B in Q4 profit

Fierce Healthcare

Industry giant UnitedHealth Group kicked off fourth-quarter earnings for major payers on Friday morning, where it reported $5.5 billion in profit. | Industry giant UnitedHealth Group kicked off fourth-quarter earnings for major payers on Friday morning, where it reported $5.5 billion in profit.

143
143
article thumbnail

Opinion: The emergency room is where the United States’ social problems come home to roost

STAT

From “ Legacy ” by Uché Blackstock, M.D., published by Viking, an imprint of Penguin Publishing Group, a division of Penguin Random House, LLC. Copyright © 2024 by Uché Blackstock, M.D. In the U.S., access to health care has long depended on insurance and a person’s ability to pay, with patients of color making up a disproportionate number of the under- or uninsured, as I have seen firsthand.

Insurance 145
article thumbnail

JPM: Four ways FDA is seeking to buoy gene therapy

pharmaphorum

Dr Peter Marks, director of the FDA Center for Biologics Evaluation and Research told a packed house in San Francisco for JPM that FDA wants to support gene therapies in 2024.

FDA 138
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

FDA Approves BrainSee, First-in-Class Test to Predict Progression of Alzheimer Disease

Pharmacy Times

BrainSee creates a new standard for progression prediction in Alzheimer disease, marking a step forward in brain health management with non-invasive screening.

FDA 178
article thumbnail

Millions of doses of Pfizer's Paxlovid will go to waste in UK, EU as COVID demand plummets

Fierce Pharma

On the heels of a major Paxlovid inventory write-off in the United States, many more doses of Pfizer's COVID-fighting antiviral are going to waste overseas. | At the end of November, more than 1.5 million courses of Pfizer’s Paxlovid had expired unused in European countries, analysts at Airfinity said in a new report. The total tally of expired doses in Europe is expected to hit 3.1 million by the end of next month, representing a value of $2.2 billion.

135
135
article thumbnail

Bipartisan Lawmakers Signal Support for H.R. 1770

Drug Topics

The Equitable Community Access to Pharmacist Services Act seeks to ensure that seniors in rural and underserved communities have access to care and services from pharmacists for common infectious diseases.

224
224
article thumbnail

JPM24: Amazon rolls out service to connect customers with digital health benefits, taps Omada Health as launch partner

Fierce Healthcare

SAN FRANCISCO—Amazon plans to collaborate with digital health companies to connect customers with virtual care benefits for managing conditions like diabetes and hypertension. | Amazon plans to collaborate with digital health companies to connect customers with virtual care benefits for managing conditions like diabetes and hypertension. The online retail giant tapped virtual-first chronic care provider Omada Health as its first partner.

141
141
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

STAT+: Can Wegovy treat depression as well as obesity? New research looks to GLP-1 drugs for mental illnesses

STAT

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied to treat an entirely different growing health problem: mental health illnesses, including depression and bipolar disorder. Early data and anecdotes suggest that this class of GLP-1 drugs could help patients feel less depressed and anxious.

145
145
article thumbnail

Why amplifying the patient voice is crucial to clinical trial success

pharmaphorum

Amplifying the patient voice is essential for the success of clinical trials. Learn why it is crucial for patient engagement, recruitment, and overall trial success, and how it can address challenges such as transportation and financial barriers.

131
131
article thumbnail

Statins Could Potentially Slow Deterioration of Cognitive Function for Those With Alzheimer Disease

Pharmacy Times

Due to the observational nature of the study, the study authors said they cannot determine causal relationships between statins and cognitive decline for patients with Alzheimer disease.

177
177
article thumbnail

Former Pfizer statistician found guilty of insider trading on Paxlovid trial results

Fierce Pharma

A jury has found a former Pfizer statistician guilty of insider trading after a two-week trial in federal court in the Southern District of New York. | A federal jury has found a former Pfizer statistician guilty of insider trading after a two-week trial in Manhattan. The jury convicted Amit Dagar, 44, of Hillsborough, N.J., of using advance information on successful trial results for Pfizer’s COVID-19 treatment Paxlovid to make more than $270,000 in stock trades.

134
134
article thumbnail

Pharmacist Interventions May Improve Clinical Outcomes of Patients With T2D

Drug Topics

By getting involved in patient care, pharmacists can help alleviate the burdens associated with the self-management of type 2 diabetes (T2D).

article thumbnail

Humana's stock tumbles pre-market as it posts $541M loss in Q4

Fierce Healthcare

Humana primed the pump last week for a disappointing fourth quarter call, and its stock again dropped Thursday morning as the company posted a $541 million loss. | Humana primed the pump last week for a disappointing fourth quarter call, and its stock again dropped Thursday morning as the company posted a $541 million loss.

138
138
article thumbnail

STAT+: Years after a polarizing approval, Biogen walks away from Aduhelm

STAT

Biogen is giving up its ownership of Aduhelm , the Alzheimer’s disease treatment whose 2021 approval led to scrutiny and outrage, turning the page on a tempestuous chapter in the company’s long history. Neurimmune, the Swiss company that invented Aduhelm, will regain full rights to the intravenous medicine, Biogen said Wednesday. Biogen will also terminate an ongoing clinical trial meant to prove the treatment’s benefits for patients in the early stages of Alzheimer’s

145
145
article thumbnail

Pharma Horizons: Artificial Intelligence

European Pharmaceutical Review

The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceutical manufacturing and quality control. AI/ML is predicted to be the top technology investment for 60 percent of life sciences companies over the next two years, according to a recent survey 1 from the Pistoia Alliance.

130
130
article thumbnail

Poor Sleep Quality in Early Adulthood Linked With Worse Cognitive Performance in Middle Age

Pharmacy Times

The risk of poor cognitive performance was nearly double in participants who had the greatest number of sleep disturbances compared to the least.

177
177
article thumbnail

Pfizer's layoff campaign ramps back up with dozens of SF-area cuts expected next month

Fierce Pharma

The start of the new year doesn’t seem to have dulled the zeal of Pfizer’s global cost-cutting campaign, which has already left hundreds of jobs in its wake. | Come mid-February, Pfizer will lay off some 52 employees at a facility in South San Francisco, according to a recent Worker Adjustment and Retraining Notification Act alert. The site is the former headquarters of Global Blood Therapeutics.

130
130
article thumbnail

Work Pressure During COVID-19 Pandemic Increased Problematic Substance Use Among First Responders

Drug Topics

Problematic substance use was highest among firefighters, followed by emergency medical technicians, and police officers.

220
220
article thumbnail

CES 2024: Older seniors are happily living with AI—in the form of chatty robot ElliQ

Fierce Healthcare

LAS VEGAS — With all the buzz and headlines about artificial intelligence, there is one demographic that is quietly embracing the technology and even building long-term relationships with it. | With all the buzz and headlines about artificial intelligence, there is one demographic that is quietly embracing the technology and even building long-term relationships with it.

137
137
article thumbnail

STAT+: Judge skeptical of arguments against Medicare drug price negotiation

STAT

WILMINGTON, Del. — Wednesday was the first time that a federal judge asked questions in-person of drug industry lawyers who are trying to stop Medicare from negotiating drug prices. It didn’t go well for them. AstraZeneca’s lawyers argued that Medicare’s new powers amount to a taking of their property rights without due process.

145
145
article thumbnail

Pfizer COVID-19 Vaccine Significantly Protected Children, Adolescents During Pandemic

Drug Topics

The estimated efficacy of the vaccine against documented infection for children and adolescents during the Omicron wave was 74.3% and 85.5%, respectively.

Vaccines 219
article thumbnail

Dexcom Submits New CGM For Non-Insulin Type 2 Diabetes for FDA Clearance

Drug Topics

Although continous glucose monitors (CGMs) have often been tailored to patients with type 1 diabetes, data elicited by these technologies add value to the management of type 2 diabetes by offering insights into patients’ unique responses to food, activity, medications, and more.

FDA 212